Vertex Pharmaceuticals Incorporated
DE ˙ XTRA ˙ US92532F1003
368,15 € ↑3,40 (0,93%)
2026-06-04
DEL PRIS
SecurityDE:VX1 / Vertex Pharmaceuticals Incorporated
InstitutionCentiva Capital, LP
Latest Disclosed Ownership2,147 shares
Latest Disclosed Value $ 958,721
Centiva Capital, LP ownership in VX1 / Vertex Pharmaceuticals Incorporated

On May 14, 2026 - Centiva Capital, LP filed a 13F-HR form disclosing ownership of 2,147 shares of Vertex Pharmaceuticals Incorporated (DE:VX1) valued at $826,810 USD as of March 31, 2026. The entity filed a previous 13F-HR on August 13, 2025 disclosing 0 shares of Vertex Pharmaceuticals Incorporated. The current value of the position is $790,418 USD.

Centiva Capital, LP has a history of taking positions in derivatives of the underlying security (VX1) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:VX1 / Vertex Pharmaceuticals Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,147 2,147 959 0.0071
2025-08-13 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -425 -100.00 0 -100.00
2025-05-15 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 425 -832 -66.19 206 -59.29 0.0062
2025-02-14 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,257 -1,768 -58.45 506 -64.01 0.0104
2024-11-14 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,025 138 4.78 1,407 3.92 0.0278
2024-08-14 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,887 579 25.09 1,353 40.35 0.0229
2024-05-15 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 2,308 1,314 132.19 965 138.61 0.0236
2024-02-14 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 994 484 94.90 404 128.25 0.0096
2023-11-14 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 510 -9,952 -95.13 177 -95.19 0.0039
2023-08-14 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 10,462 9,723 1,315.70 3,682 1,486.64 0.0806
2023-05-15 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 739 314 73.88 233 90.16 0.0057
2023-02-14 2022-12-31 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 425 -55 -11.46 123 -12.23 0.0035
2023-02-14 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 425 -55 123 0.0035
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 480 -22,020 -97.87 139 -97.81 0.0026
2022-08-15 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 22,500 22,500 6,340 0.1500
2021-11-17 2021-09-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 0 -11,053 -100.00 0 -100.00
2021-11-15 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -11,053 0
2021-08-16 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 11,053 5,757 108.70 2,229 95.87 0.0526
2021-05-17 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 5,296 1,615 43.87 1,138 30.80 0.0435
2021-02-16 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,681 1,016 38.12 870 20.00 0.0340
2020-11-16 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,665 -2,176 -44.95 725 -48.40 0.0476
2020-08-14 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 4,841 519 12.01 1,405 36.54 0.0847
2020-05-15 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 4,322 -8,552 -66.43 1,029 -63.50 0.0462
2020-02-14 2019-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 12,874 -830 -6.06 2,819 21.40 0.1378
2019-11-13 2019-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 13,704 12,496 1,034.44 2,322 950.68 0.1420
2019-08-13 2019-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,208 -2,277 -65.34 221 -65.52 0.0132
2019-05-14 2019-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,485 3,485 641 0.0431
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-13 2025-12-31 13F VERTEX PHARMACEUTICALS COM Call 50,200 -49.90 22,759 -42.01 n/a n/a n/a
2025-11-14 2025-09-30 13F VERTEX PHARMACEUTICALS COM Call 100,200 39,242 n/a n/a n/a
2025-05-15 2025-03-31 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-14 2024-12-31 13F VERTEX PHARMACEUTICALS COM Call 600 -40.00 242 -48.17 n/a n/a n/a
2024-11-14 2024-09-30 13F VERTEX PHARMACEUTICALS COM Call 1,000 0.00 465 -0.64 n/a n/a n/a
2024-08-14 2024-06-30 13F VERTEX PHARMACEUTICALS COM Call 1,000 -9.09 469 1.96 n/a n/a n/a
2024-05-15 2024-03-31 13F VERTEX PHARMACEUTICALS COM Call 1,100 -87.91 460 -87.60 n/a n/a n/a
2024-02-14 2023-12-31 13F VERTEX PHARMACEUTICALS COM Call 9,100 1.11 3,703 18.31 n/a n/a n/a
2023-11-14 2023-09-30 13F VERTEX PHARMACEUTICALS COM Call 9,000 38.46 3,130 36.82 n/a n/a n/a
2023-08-14 2023-06-30 13F VERTEX PHARMACEUTICALS COM Call 6,500 0.00 2,287 11.72 n/a n/a n/a
2023-05-15 2023-03-31 13F VERTEX PHARMACEUTICALS COM Call 6,500 -68.29 2,048 -65.42 n/a n/a n/a
2023-02-14 2022-12-31 13F/A VERTEX PHARMACEUTICALS COM Call 20,500 -19.61 5,920 -19.84 n/a n/a n/a
2023-02-14 2022-12-31 13F VERTEX PHARMACEUTICALS COM Call 20,500 5,920 n/a n/a n/a
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM Call 25,500 88.89 7,384 94.11 n/a n/a n/a
2022-08-17 2022-06-30 13F/A VERTEX PHARMACEUTICALS COM Call 13,500 -4.26 3,804 3.40 n/a n/a n/a
2022-05-16 2022-03-31 13F VERTEX PHARMACEUTICALS COM Call 14,100 182.00 3,679 235.06 n/a n/a n/a
2022-02-14 2021-12-31 13F VERTEX PHARMACEUTICALS COM Call 5,000 1,098 n/a n/a n/a
2021-11-17 2021-09-30 13F/A VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F VERTEX PHARMACEUTICALS COM Call 0 0 n/a n/a n/a
2021-08-16 2021-06-30 13F VERTEX PHARMACEUTICALS COM Call 5,000 1,008 n/a n/a n/a
2021-02-16 2020-12-31 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-16 2020-09-30 13F VERTEX PHARMACEUTICALS COM Call 4,100 0.00 1,115 -6.38 n/a n/a n/a
2020-08-14 2020-06-30 13F VERTEX PHARMACEUTICALS COM Call 4,100 -45.33 1,191 -33.28 n/a n/a n/a
2020-05-15 2020-03-31 13F VERTEX PHARMACEUTICALS COM Call 7,500 82.93 1,785 49.87 n/a n/a n/a
2019-08-13 2019-06-30 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-14 2019-03-31 13F VERTEX PHARMACEUTICALS COM Call 1,500 276 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-05-15 2025-03-31 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-14 2024-12-31 13F VERTEX PHARMACEUTICALS COM Put 3,000 -25.00 1,208 -35.05 n/a n/a n/a
2024-11-14 2024-09-30 13F VERTEX PHARMACEUTICALS COM Put 4,000 0.00 1,860 -0.75 n/a n/a n/a
2024-08-14 2024-06-30 13F VERTEX PHARMACEUTICALS COM Put 4,000 0.00 1,875 12.08 n/a n/a n/a
2024-05-15 2024-03-31 13F VERTEX PHARMACEUTICALS COM Put 4,000 -64.60 1,672 -63.63 n/a n/a n/a
2024-02-14 2023-12-31 13F VERTEX PHARMACEUTICALS COM Put 11,300 126.00 4,598 164.50 n/a n/a n/a
2023-11-14 2023-09-30 13F VERTEX PHARMACEUTICALS COM Put 5,000 1,739 n/a n/a n/a
2023-05-15 2023-03-31 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-14 2022-12-31 13F/A VERTEX PHARMACEUTICALS COM Put 6,000 0.00 1,733 -0.35 n/a n/a n/a
2023-02-14 2022-12-31 13F VERTEX PHARMACEUTICALS COM Put 6,000 1,733 n/a n/a n/a
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM Put 6,000 -33.33 1,738 -31.47 n/a n/a n/a
2022-08-17 2022-06-30 13F/A VERTEX PHARMACEUTICALS COM Put 9,000 -48.86 2,536 -44.77 n/a n/a n/a
2022-05-16 2022-03-31 13F VERTEX PHARMACEUTICALS COM Put 17,600 252.00 4,592 318.21 n/a n/a n/a
2022-02-14 2021-12-31 13F VERTEX PHARMACEUTICALS COM Put 5,000 1,098 n/a n/a n/a
2021-11-17 2021-09-30 13F/A VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F VERTEX PHARMACEUTICALS COM Put 0 0 n/a n/a n/a
2021-08-16 2021-06-30 13F VERTEX PHARMACEUTICALS COM Put 15,000 3,024 n/a n/a n/a
2021-02-16 2020-12-31 13F VERTEX PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-16 2020-09-30 13F VERTEX PHARMACEUTICALS COM Put 4,300 0.00 1,170 -6.25 n/a n/a n/a
2020-08-14 2020-06-30 13F VERTEX PHARMACEUTICALS COM Put 4,300 -67.91 1,248 -60.87 n/a n/a n/a
2020-05-15 2020-03-31 13F VERTEX PHARMACEUTICALS COM Put 13,400 10.74 3,189 20.39 n/a n/a n/a
2020-02-14 2019-12-31 13F VERTEX PHARMACEUTICALS COM Put 12,100 -3.20 2,649 25.07 n/a n/a n/a
2019-11-13 2019-09-30 13F VERTEX PHARMACEUTICALS COM Put 12,500 635.29 2,118 581.03 n/a n/a n/a
2019-08-13 2019-06-30 13F VERTEX PHARMACEUTICALS COM Put 1,700 -84.82 311 -84.90 n/a n/a n/a
2019-05-14 2019-03-31 13F VERTEX PHARMACEUTICALS COM Put 11,200 2,059 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.